The Business Times
SUBSCRIBERS

Hedge funds stung by mega-deal collapse

But no-go on Pfizer-Allergan merger mitigated by mix of of earlier optimism and reluctance on taking super-size positions

Published Thu, Apr 7, 2016 · 09:50 PM

London

HEDGE funds which bet on mergers and acquisitions were hurt by the collapse of a US$160 billion tie-up between pharmaceutical companies Pfizer and Allergan - although the effects could have been even worse.

The deal was pulled after the US Treasury drafted new rules to deter companies from moving their headquarters to countries with a more favourable tax regime, so called "tax inversions", echoing the failed merger between Shire and AbbVie in 2014 which hurt many funds.

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Banking & Finance

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here